Dr. Sharon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9609 Medical Center Drive
Room 5W512
Bethesda, MD 20892Phone+1 240-276-6565- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2007 - 2011
- Emory University School of MedicineResidency, Internal Medicine, 2003 - 2006
- Baylor College of MedicineClass of 2003
Certifications & Licensure
- MA State Medical License 2008 - 2026
- DC State Medical License 2012 - 2024
- GA State Medical License 2006 - 2017
- MD State Medical License 2012 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Perspective: The COVID-19 Pandemic: Closing Borders, Opening Doors, and Breaking Ground on the Potential for Clinical Trial Access in Developing Countries Like Trinida...Kellie Alleyne-Mike, John Glod, Erissa Cuffie, Rajiv Kissoon, Bernard Bedaysie, Pearse Sylvester, Matthew Boron, J Michelle Brockman, Nancy Moore, Alice P Chen, Elad S...> ;JCO Global Oncology. 2024 May 1
- Exacerbation of CMV and Nontuberculous Mycobacterial Infections Following PD-1 Blockade for HIV-Associated Kaposi Sarcoma.Shunsuke Sakai, Kelsie Brooks, Steven P Fling, Cecilia S Lindestam Arlehamn, Alessandro Sette, Kenneth S Knox, Jason M Brenchley, Daniel L Barber, Ifeanyichukwu U Anid...> ;Open Forum Infectious Diseases. 2024 May 1
- 1 citationsNivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers.Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I Khushalani, Jason J Luke, Patrick A Ott, Jeffrey A Sosman, Vikram Aggarwa...> ;Journal of Clinical Oncology. 2024 Mar 20
- Join now to see all
Journal Articles
- Pembrolizumab in Mycosis Fungoides and Sézary Syndrome: Updated Results of the CITN Multicenter Phase 2 StudyMichael S Khodadoust, Pierluigi Porcu, Francine Foss, Andrei R Shustov, Satish Shanbhag, Lubomir Sokol, Steven M Horwitz, Elad Sharon, European Journal of Cancer
- Immuno-Oncology Trial Endpoints: Capturing Clinically Meaningful ActivityElad Sharon, Patrick M Forde, Valsamo Anagnostou, Hao Wang, Franco Verde, Mark Yarchoan, Clinical Cancer Research
- From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials WiselyArta M Monjazeb, Elad Sharon, Clinical Cancer Research
Authored Content
- Pembrolizumab in Mycosis Fungoides and Sézary Syndrome: Updated Results of the CITN Multicenter Phase 2 StudyAugust 2018
Press Mentions
- Rare Melanoma Very Likely to Respond to Treatment with PembrolizumabMay 5th, 2023
- Drug Approved to Help Young Patients Battle a Rare CancerJanuary 2nd, 2023
- Slips, Slides: Winter Injuries Can Be SeriousJanuary 2nd, 2023
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- NIH Clinical CenterBethesda, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: